Hershey, PA, United States of America

Steven K Burkhead


 

 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 21(Granted Patents)


Location History:

  • Seattle, WA (US) (1996 - 1998)
  • Hershey, PA (US) (2003 - 2012)

Company Filing History:


Years Active: 1996-2012

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Steven K Burkhead

Introduction

Steven K Burkhead is a notable inventor based in Hershey, PA (US). He has made significant contributions to the field of medical research, particularly in the treatment of multiple sclerosis. With a total of 9 patents to his name, Burkhead's work focuses on innovative methods that target inflammatory processes in human diseases.

Latest Patents

Among his latest patents is a groundbreaking method for treating multiple sclerosis (MS) using an IL-17A and IL-17F antagonist. This invention relates to blocking, inhibiting, reducing, antagonizing, or neutralizing the activity of IL-17F, IL-17A, or both IL-17A and IL-17F polypeptide molecules. IL-17A and IL-17F are cytokines that play a crucial role in inflammatory processes and various human diseases. Additionally, Burkhead's patent includes soluble ZcytoR14, anti-ZcytoR14 antibodies, and binding partners, along with methods for antagonizing IL-17F, IL-17A, or both using these soluble receptors and antibodies. Another significant invention is the identification of a new human cytokine receptor designated as 'Zcytor14,' which has proven useful in both basic research and therapeutic applications.

Career Highlights

Burkhead's career is marked by his dedication to advancing medical science through innovative research. His work at Zymogenetics, Inc. has positioned him as a key figure in the development of new therapeutic strategies for treating autoimmune diseases. His extensive research and patent portfolio reflect his commitment to improving patient outcomes through scientific innovation.

Collaborations

Throughout his career, Burkhead has collaborated with esteemed colleagues, including Scott R Presnell and Sarah L Pownder. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in the field of cytokine research.

Conclusion

Steven K Burkhead's contributions to medical research and his innovative patents highlight his role as a leading inventor in the field. His work continues to pave the way for new treatments that address complex health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…